Exudative Lymphocytic Pleural Effusion: Differential Diagnosis

Major Causes

The primary causes of an exudative, lymphocytic pleural effusion are tuberculosis and malignancy, with tuberculosis being the most common infectious etiology and malignancy accounting for 42-77% of all exudative effusions, according to the American Thoracic Society 1, 2
Lung carcinoma accounts for approximately one-third of all malignant effusions and is the leading malignant cause, as stated by the American College of Chest Physicians 2, 3
Breast carcinoma is the second most common malignancy causing lymphocytic effusions, as reported by the American College of Chest Physicians 2, 4
Lymphomas (both Hodgkin's and non-Hodgkin's) represent approximately 10% of malignant pleural effusions and characteristically present with lymphocyte-predominant exudates, according to the American Thoracic Society 5, 4

Systemic lupus erythematosus (SLE) affects up to 50% of patients during disease course and produces lymphocytic exudates, as stated by the European League Against Rheumatism 3
Multiple myeloma causes effusions in approximately 6% of cases with characteristically high pleural protein values, as reported by the American College of Chest Physicians 5, 4

Light's criteria should be applied first to confirm exudative nature (sensitivity 98%, specificity 72%), as recommended by the European Respiratory Society 6
Cytology achieves approximately 80% diagnostic yield in malignancy but only 31-55% in lymphoma, according to the American Thoracic Society 5, 3
Thoracoscopy has a superior diagnostic yield, particularly for lymphoma (85% sensitivity with chromosome analysis) and when malignancy is suspected after routine tests fail, as stated by the American College of Chest Physicians 5, 3
Empirical anti-tuberculous therapy may be justified with positive tuberculin skin test and exudative lymphocytic effusion in appropriate clinical context, as recommended by the American Thoracic Society 3
Reconsider pulmonary embolism and TB in persistent undiagnosed effusions, as both are amenable to specific treatment, as stated by the European Society of Cardiology 3
Pleural fluid ANA testing is not helpful in diagnosing SLE as it merely mirrors serum levels, according to the American College of Rheumatology 3

The European Respiratory Society recommends performing thoracic ultrasound on every patient at initial presentation to assess safety of diagnostic aspiration, effusion size, and character, and to look for nodularity of the diaphragm and parietal pleura, which are highly suggestive of malignancy 7
The British Thoracic Society suggests obtaining a CT chest/abdomen/pelvis if malignancy is suspected, with a diagnostic yield of approximately 80% for cytology in malignancy 7

The American Thoracic Society advises always obtaining detailed occupational history, including asbestos exposure, when investigating all pleural effusions, as history of asbestos exposure should raise suspicion for mesothelioma 7
The European Respiratory Society recommends reviewing medication history carefully, as tyrosine kinase inhibitors are now the most common drugs causing exudative pleural effusions 7

Approximately 10 % of malignant pleural effusions are caused by Hodgkin’s or non‑Hodgkin’s lymphoma and typically present as lymphocyte‑predominant exudates. 8, 9
In Hodgkin’s disease, the principal mechanism is obstruction of lymphatic drainage by enlarged mediastinal lymph nodes. 8, 9
In non‑Hodgkin’s lymphoma, direct infiltration of the parietal or visceral pleura is the dominant mechanism. 8, 9
Lymphoma‑related effusions may be serous, hemorrhagic, or chylous; non‑Hodgkin’s lymphoma is the most common cause of chylothorax. 8, 9

Effusions occur in roughly 6 % of patients with multiple myeloma and are characterized by markedly elevated pleural protein concentrations. 8

Pleural fluid cytology yields a diagnostic sensitivity of about 80 % for malignant effusions overall, but only 31–55 % for lymphoma, with the lowest yield in Hodgkin’s disease. 8, 9

Pleural fluid pH and glucose levels correlate with overall prognosis but have limited value in predicting successful pleurodesis. 8

Medical thoracoscopy provides superior diagnostic yield, especially for lymphoma, achieving approximately 85 % sensitivity when chromosome analysis is incorporated. 8, 9

Flow cytometric analysis of pleural fluid can demonstrate clonal lymphoid populations and should be performed when lymphoma is suspected. 8, 9